Status:

NOT_YET_RECRUITING

Prevention of Vasovagal Reactions in First-time Blood Donors Using a Combined PSYchological and Physiological Approach

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Vasovagal Reaction

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The prevention of vasovagal reactions (VVR) occurring during or after donation is a major issue for the French Blood Establishment (EFS), firstly to guarantee the safety of donors but also to retain t...

Eligibility Criteria

Inclusion

  • M/F between 18 and 70 years old,
  • A first-time donor who wishes to donate blood in Lyon, either at a fixed site or at a mobile unit,
  • Declared fit to donate whole blood after the EFS pre-donation interview,
  • Weight ≥ 50kg and height ≥ 135 cm,
  • Available for telephone contact between to 5d +/- 2 days after donation,
  • Having signed a written consent to participate in the study.
  • Non-inclusion criteria:
  • Known allergy to shellfish, and/or gluten, and/or milk, and/or soy,
  • Incomprehension of the French language,
  • First-time donor under protective measures (guardian, curator) or any other administrative measure,
  • Not affiliated to the French social security system or any other equivalent system,
  • Pregnant or breastfeeding woman,
  • Subject participating in any other interventional or non-interventional research

Exclusion

  • Withdrawal of consent
  • First-time donor with anemia following routine hemoglobin testing
  • First-time donor not reachable for telephone interview

Key Trial Info

Start Date :

October 10 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 18 2026

Estimated Enrollment :

5320 Patients enrolled

Trial Details

Trial ID

NCT06014346

Start Date

October 10 2023

End Date

August 18 2026

Last Update

October 4 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

French Blood Establishment (EFS)

Lyon, France, 69153